Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...
Some you might hold only temporarily, while others you own for decades. David Jagielski (Eli Lilly): A forever stock you can ...
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
A GOL Airlines Boeing 737 MAX 8 collided with a service vehicle during takeoff at Rio de Janeiro-Galeão International Airport ...
Q4 2024 Earnings Conference Call February 6, 2025 2:00 AM ETCompany ParticipantsRonojoy Banerjee - Communications ...
Hosted on MSN22d
Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared HolzJared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk's recent climb ... who simply vanished without a trace What Is A Camless Engine And Which Cars Have One? China Strikes Back Over ...
Gardasil shipment pause, weak guidance, and looming Keytruda risks send investors scrambling--can Merck turn things around?
He also sardonically targeted co-host David Faber and said “Look I’m sure that when they discovered the cotton gin, and ...
European companies are set to deliver a third straight quarter of profit growth, which may help to maintain newfound investor enthusiasm for the region despite political and economic turmoil and ...
New Jersey-based Onkos Surgical ®, whose goal is to solve seemingly impossible surgical problems like infection risk or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results